Related Experiment Video
Updated: Sep 14, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Overexpressed MicroRNA-455-3p enhances cognitive function in late-onset Alzheimer's disease
Md Ariful Islam1, Sudhir Kshirsagar1, Rainier Vladlen Alvir1
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
MicroRNA-455-3p (miR-455-3p) enhances cognitive and motor functions. Its overexpression offers neuroprotection, while its absence worsens Alzheimer's disease (AD) symptoms in mice.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are critical regulators in neurodegenerative diseases like Alzheimer's disease (AD).
- The specific role of miR-455-3p in cognitive and motor functions related to AD was previously unexplored.
Purpose of the Study:
- To investigate the impact of miR-455-3p overexpression and knockout on cognitive and motor behaviors in a humanized amyloid beta (hAbKI) mouse model of AD.
Main Methods:
- Generated double mutant mice by crossing miR-455-3p transgenic (TG) and knockout (KO) mice with hAbKI mice.
- Assessed cognitive and motor functions using Morris Water Maze, Y-maze, open field, and rotarod tests across six experimental groups.
Main Results:
- miR-455-3p overexpression significantly improved locomotor activity, working memory, spatial learning, and motor coordination.
- miR-455-3p knockout impaired cognitive and motor performance and increased anxiety-like behavior.
- The hAbKI x miR-455-3p KO group showed the most severe deficits, indicating miR-455-3p loss exacerbates AD-related impairments.
Conclusions:
- miR-455-3p plays a crucial role in regulating cognitive and motor functions.
- Overexpression of miR-455-3p demonstrates neuroprotective benefits.
- Targeting miR-455-3p presents a potential therapeutic strategy for improving outcomes in AD and related disorders.
More Related Videos
09:06Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome
Published on: June 10, 2013
07:55Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
MicroRNAs
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists